Tuberculosis in patients with end-stage renal disease

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 1, 2004, Pages 92-97

  Fang, H C ^a,b   Lee, P T ^a   Chen, C L ^a   Wu, M J ^a   Chou, Kang Ju ^a,b   Chung, H M ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

End stage renal disease; Hypercalcaemia; Mortality; Tuberculosis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ETHAMBUTOL; GLOBULIN; ISONIAZID; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; DEATH; DIALYSIS; DISEASE ASSOCIATION; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY; UREMIA;

AGE DISTRIBUTION; AGED; ANTITUBERCULAR AGENTS; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 1642516191     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72: 1-6.
2. Lewis S L, Van Epps D E. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987; 9: 381-395.
3. Pradhan R P, Katz L A, Nidus B D, Matalon R, Eisinger R P. Tuberculosis in dialyzed patients. JAMA 1974; 229: 798-800.
4. Sasaki S, Akiba T, Suenaga M, et al. Ten years' survey of dialysis-associated tuberculosis. Nephron 1979; 24: 141-145.
5. Lundin A P, Adler A J, Berlyne G M, Friedman E A. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979; 67: 597-602.
6. Andrew O T, Schoenfeld P Y, Hopewell P C, Humphreys M H. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59-65.
7. Rutsky E A, Rostand S G. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med 1980; 140: 57-61.
8. Malhotra K K, Parashar M K, Sharma R K, et al. Tuberculosis in maintenance haemodialysis patients. Study from an endemic area. Postgrad Med J 1981; 57: 492-498.
9. Belcon M C, Smith E K, Kahana L M, Shimizu A G. Tuberculosis in dialysis patients. Clin Nephrol 1982; 17: 14-18.
10. Nishiwaki K, Iwakura M, Sugiyama S, Amano I, Shimokata K. Clinical studies of tuberculosis in hemodialysis patients. Kekkaku 1983; 58: 509-514.
11. Cuss F M, Carmichael D J, Linington A, Hulme B. Tuberculosis in renal failure: a high incidence in patients born in the Third World. Clin Nephrol 1986; 25: 129-133.
12. Tolkoff-Rubin N E, Rubin R H. Uremia and host defenses. N Engl J Med 1990; 322: 770-772.
13. Huber H, Pastner D, Dittrich P, Braunsteiner H. In vitro reactivity of human lymphocytes in uraemia-a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol 1969; 5: 75-82.
14. Lai Y S, Hwang S J, Yang W C, et al. Dialysis therapy in Taiwan-1996 annual report. Acta Nephrologica Taiwan Society of Nephrology 1996; 10: 163-184.
15. Kelestimur F, Guven M, Ozesmi M, Pasaoglu H. Does tuberculosis really cause hypercalcemia? J Endocrinol Invest 1996; 19:678-681.
16. Fuss M, Karmali R, Pepersack T, et al. Are tuberculous patients at a great risk from hypercalcemia? Q J Med 1988; 69: 869-878.
17. Liam C K, Lim K H, Srinivas P, Poi P J. Hypercalcaemia in patients with newly diagnosed tuberculosis in Malaysia. Int J Tuberc Lung Dis 1998; 2: 818-823.
18. Chan T Y. Differences in vitamin D status and calcium intake: possible explanations for the regional variations in the prevalence of hypercalcemia in tuberculosis. Calcif Tissue Int 1997; 60: 91-93.
19. Kitrou M P, Phytou-Pallikari A, Tzannes S E, Virvidakis K, Mountokalakis T D. Serum calcium during chemotherapy for active pulmonary tuberculosis. Eur J Respir Dis 1983; 64: 347-354.
20. Davies P D, Church H A, Brown R C, Woodhead J S. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987; 71: 341-344.
21. Abbasi A A, Chemplavil J K, Farah S, Muller B F, Arnstein A R. Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med 1979; 90: 324-328.
22. Cadranel J L, Garabedian M, Milleron B, et al. Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations. Eur Respir J 1994; 7: 1103-1110.
23. Gkonos P J, London R, Hendler E D. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with endstage renal disease and active tuberculosis. N Engl J Med 1984; 311:1683-1685.
24. Lafferty F W. Differential diagnosis of hypercalcemia. J Bone Miner Res 1991; 6 (Suppl 2): S51-S59.
25. Sharma O P. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000; 6: 442-447.
26. Jan S P, Jian I S, Sou Z, Lin D P, Lu K T. The serum concentration of calcium in pulmonary tuberculosis. Shiou Chiang I Hsueh 1996; 11: 224-229.
27. Zhang X, Hou F, Wei D. Tuberculosis in chronic renal failure patients with or without renal replacement therapy. Chung Hua Nei Ko Tsa Chih 1995; 34: 666-669.
28. Shohaib S A, Scrimgeour E M, Shaerya E Tuberculosis in active dialysis patients in Jeddah. Am J Nephrol 1999; 19: 34-37.
29. Inamoto H. High susceptibility and low resistance to lymph node tuberculosis in dialysis patients. Kansenshogaku Zasshi 1983; 57: 137-141.
30. Chou K J, Fang H C, Bai K J, Hwang S J, Yang W C, Chung H M. Tuberculosis in maintenance dialysis patients. Nephron 2001; 88:138-143.
31. Woods G L, Washington J A. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9: 275-294.